Kamada director sells 177,173 shares at $8.26–$8.28

Q: Who from KMDA reported insider transactions and in what role?

The filing reports transactions by David Tsur, who is identified as a director of KAMADA LTD (KMDA). No officer or ten‑percent owner status is indicated in this Form 4.

Q: At what prices were the KMDA shares sold in these transactions?

The shares were sold at U.S. dollar prices of $8.28 per share on September 7, 2026, and $8.26 per share on both September 8 and September 9, 2026. The filing notes these are convenience conversions from New Israeli Shekels.

Q: Were the KMDA insider sales made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that no Rule 10b5‑1 trading plan is reported for these transactions, and the document‑level 10b5‑1 checkbox is not marked as being made pursuant to such a plan.

Q: How were the KMDA sale prices converted into U.S. dollars?

For each transaction date, the U.S. dollar sale price is a convenience conversion from New Israeli Shekels, based on the exchange rate published by the Bank of Israel as of September 7, 8, and 9, 2026, respectively.

KAMADA LTD (KMDA) director David Tsur reported open‑market sales of a total of 177,173 Ordinary Shares over three days in September 2026.

Available on EDGAR 09/11/2026 - 11:30 AM EDT Accepted by SEC EDGAR 09/11/2026 - 11:29 AM EDT

Filing Impact

(Neutral)

Filing Sentiment

(Negative)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

KAMADA LTD (KMDA) director David Tsur reported open‑market sales of a total of 177,173 Ordinary Shares over three days in September 2026. He sold 14,238 shares on September 7 at $8.28, 162,760 shares on September 8 at $8.26, and 175 shares on September 9 at $8.26. The U.S. dollar prices are convenience conversions from New Israeli Shekels based on Bank of Israel exchange rates for each respective date, and no Rule 10b5‑1 trading plan is reported.

Insider Trade Summary

Net Seller: 177,173 shares

Net Sell 3 txns

Insider Tsur David

Role Director

Sold 177,173 shs ($1.46M)

Share of Position Sold 29.1%

Type	Security	Shares	Price	Value
Sale	Ordinary Shares ^F3	175	$8.26	$1K
Sale	Ordinary Shares ^F2	162,760	$8.26	$1.34M
Sale	Ordinary Shares ^F1	14,238	$8.28	$118K

Holdings After Transaction: Ordinary Shares — 430,756 shares (Direct)

Holdings Before and After: Ordinary Shares, 607,929 to 430,756 shares (Direct)

Footnotes (3)

F1. The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 7, 2026.
F2. The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 8, 2026.
F3. The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 9, 2026.

Key Figures

Total shares sold: 177,173 Ordinary Shares Shares sold on September 7, 2026: 14,238 shares Price on September 7, 2026: $8.28 per share +4 more

7 metrics

Total shares sold 177,173 Ordinary Shares Aggregate of all reported sales from September 7–9, 2026

Shares sold on September 7, 2026 14,238 shares Open‑market sale of Ordinary Shares

Price on September 7, 2026 $8.28 per share Convenience conversion from NIS using Bank of Israel rate

Shares sold on September 8, 2026 162,760 shares Open‑market sale of Ordinary Shares

Price on September 8, 2026 $8.26 per share Convenience conversion from NIS using Bank of Israel rate

Shares sold on September 9, 2026 175 shares Open‑market sale of Ordinary Shares

Price on September 9, 2026 $8.26 per share Convenience conversion from NIS using Bank of Israel rate

Key Terms

Ordinary Shares, convenience conversion, exchange rate

3 terms

Ordinary Shares financial

"reported open‑market sales of a total of 177,173 Ordinary Shares"

Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.

convenience conversion financial

"sale price presented in U.S. dollars represents a convenience conversion from NIS"

exchange rate financial

"based on the exchange rate published by the Bank of Israel"

Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who from KMDA reported insider transactions and in what role?

The filing reports transactions by David Tsur, who is identified as a director of KAMADA LTD (KMDA). No officer or ten‑percent owner status is indicated in this Form 4.

How many KMDA shares did the director sell in this Form 4?

Across the reported transactions, the director sold a total of 177,173 Ordinary Shares of KAMADA LTD. This consists of 14,238 shares on September 7, 162,760 shares on September 8, and 175 shares on September 9, 2026.

At what prices were the KMDA shares sold in these transactions?

The shares were sold at U.S. dollar prices of $8.28 per share on September 7, 2026, and $8.26 per share on both September 8 and September 9, 2026. The filing notes these are convenience conversions from New Israeli Shekels.

Were the KMDA insider sales made under a Rule 10b5-1 trading plan?

No. The Form 4 indicates that no Rule 10b5‑1 trading plan is reported for these transactions, and the document‑level 10b5‑1 checkbox is not marked as being made pursuant to such a plan.

How were the KMDA sale prices converted into U.S. dollars?

For each transaction date, the U.S. dollar sale price is a convenience conversion from New Israeli Shekels, based on the exchange rate published by the Bank of Israel as of September 7, 8, and 9, 2026, respectively.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tsur David

(Last)

(First)

(Middle)

2 HOLTZMAN ST.

(Street)

REHOVOT

(City)

(State)

(Zip)

ISRAEL

(Country)

2. Issuer Name and Ticker or Trading Symbol
KAMADA LTD [ KMDA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	09/07/2026		S		14,238	D	$8.28⁽¹⁾	593,691	D
Ordinary Shares	09/08/2026		S		162,760	D	$8.26⁽²⁾	430,931	D
Ordinary Shares	09/09/2026		S		175	D	$8.26⁽³⁾	430,756	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 7, 2026.

2. The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 8, 2026.

3. The sale price presented in U.S. dollars represents a convenience conversion from NIS based on the exchange rate published by the Bank of Israel as of September 9, 2026.

	/s/ David Tsur	09/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR